{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:46:18Z","timestamp":1792687578538,"version":"4.5.0"},"reference-count":23,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2015,1,30]]},"published-print":{"date-parts":[[2015,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The objective of this study was to evaluate the problem of multiple chronic conditions and polypharmacy in patients with fibromyalgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective medical record review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Olmsted County, Minnesota.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>1111 adults with fibromyalgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Number and type of chronic medical and psychiatric conditions, medication use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Medical record review demonstrated that greater than 50% of the sample had seven or more chronic conditions. Chronic joint pain\/degenerative arthritis was the most frequent comorbidity (88.7%), followed by depression (75.1%), migraines\/chronic headaches (62.4%) and anxiety (56.5%). Approximately, 40% of patients were taking three or more medications for symptoms of fibromyalgia. Sleep aids were the most commonly prescribed medications in our sample (33.3%) followed by selective serotonin reuptake inhibitors (28.7%), opioids (22.4%) and serotonin norepinephrine reuptake inhibitors (21.0%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of our study highlight the problem of multiple chronic conditions and high prevalence of polypharmacy in fibromyalgia. Clinicians who care for patients with fibromyalgia should take into consideration the presence of multiple chronic conditions when recommending medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2014-006681","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T21:33:16Z","timestamp":1425418396000},"page":"e006681","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota"],"prefix":"10.1136","volume":"5","author":[{"given":"Ann","family":"Vincent","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary O","family":"Whipple","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J","family":"McAllister","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M","family":"Aleman","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"St Sauver","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"issue":"(Suppl 3)","key":"2025121601200050000_5.3.e006681.1","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/MLR.0000000000000045","article-title":"A conceptual model of the role of complexity in the care of patients with multiple chronic conditions","volume":"52","author":"Grembowski","year":"2014","journal-title":"Med Care"},{"key":"2025121601200050000_5.3.e006681.2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000095"},{"issue":"(Suppl 3)","key":"2025121601200050000_5.3.e006681.3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/MLR.0000000000000093","article-title":"Research on multiple chronic conditions: where we are and where we need to go","volume":"52","author":"Tinetti","year":"2014","journal-title":"Med Care"},{"key":"2025121601200050000_5.3.e006681.4","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3182a51b3d"},{"key":"2025121601200050000_5.3.e006681.5","unstructured":"Partnership for Solutions. Chronic conditions: making the case for ongoing care. Johns Hopkins University, 2004."},{"key":"2025121601200050000_5.3.e006681.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380104"},{"key":"2025121601200050000_5.3.e006681.7","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21896"},{"key":"2025121601200050000_5.3.e006681.8","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders","volume":"67","author":"Arnold","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"2025121601200050000_5.3.e006681.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-007-0214-4"},{"key":"2025121601200050000_5.3.e006681.10","first-page":"726","article-title":"Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents","volume":"112","author":"Przekop","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"2025121601200050000_5.3.e006681.11","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000221817.46231.18"},{"key":"2025121601200050000_5.3.e006681.12","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e31815cff4b"},{"key":"2025121601200050000_5.3.e006681.13","unstructured":"Forest Pharmaceuticals, Inc. Savella (milnacipran hydrochloride) tablets [prescribing information]. St Louis, MO: Forest Pharmaceuticals, 2009."},{"key":"2025121601200050000_5.3.e006681.14","unstructured":"Pfizer, Inc. Lyrica (pregabalin) capusules [prescribing information]. New York, NY: Pfizer, Inc, 2009."},{"key":"2025121601200050000_5.3.e006681.15","unstructured":"Eli Lilly and Company. Cymbalta (duloxetine hydrochloride) delayed release capsules [prescribing information]. Indianapolis, IN: Eli Lilly and Company, 2008."},{"key":"2025121601200050000_5.3.e006681.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.08.012"},{"key":"2025121601200050000_5.3.e006681.17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys195"},{"key":"2025121601200050000_5.3.e006681.18","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq482"},{"key":"2025121601200050000_5.3.e006681.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100594"},{"key":"2025121601200050000_5.3.e006681.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.03.006"},{"key":"2025121601200050000_5.3.e006681.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1885-z"},{"key":"2025121601200050000_5.3.e006681.22","doi-asserted-by":"publisher","DOI":"10.1080\/030097402317255336"},{"key":"2025121601200050000_5.3.e006681.23","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.mayocp.2014.07.010","article-title":"Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race\/ethnicity","volume":"89","author":"Rocca","year":"2014","journal-title":"Mayo Clin Proc"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2014-006681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:20:08Z","timestamp":1765876808000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2014-006681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,3]]},"published-print":{"date-parts":[[2015,3]]}},"alternative-id":["10.1136\/bmjopen-2014-006681"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2014-006681","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}